AU2001289916A1 - Methods for improving the antagonistic/agonistic properties of peptidic antagonists/agonists of the corticotropin-releasing factor receptor (crfr) - Google Patents

Methods for improving the antagonistic/agonistic properties of peptidic antagonists/agonists of the corticotropin-releasing factor receptor (crfr)

Info

Publication number
AU2001289916A1
AU2001289916A1 AU2001289916A AU8991601A AU2001289916A1 AU 2001289916 A1 AU2001289916 A1 AU 2001289916A1 AU 2001289916 A AU2001289916 A AU 2001289916A AU 8991601 A AU8991601 A AU 8991601A AU 2001289916 A1 AU2001289916 A1 AU 2001289916A1
Authority
AU
Australia
Prior art keywords
crfr
corticotropin
antagonistic
agonists
improving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001289916A
Other languages
English (en)
Inventor
Klaus Eckart
Olaf Jahn
Joachim Spiess
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Publication of AU2001289916A1 publication Critical patent/AU2001289916A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57509—Corticotropin releasing factor [CRF] (Urotensin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001289916A 2000-09-22 2001-09-24 Methods for improving the antagonistic/agonistic properties of peptidic antagonists/agonists of the corticotropin-releasing factor receptor (crfr) Abandoned AU2001289916A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DE10047186.2 2000-09-22
DE10047186 2000-09-22
DE10054539 2000-11-03
DE10054539.4 2000-11-03
EP01122446 2001-09-20
EP01122446.6 2001-09-20
PCT/EP2001/011031 WO2002024732A2 (en) 2000-09-22 2001-09-24 Methods for improving the antagonistic/agonistic properties of peptidic antagonists/agonists of the corticotropin-releasing factor receptor (crfr)

Publications (1)

Publication Number Publication Date
AU2001289916A1 true AU2001289916A1 (en) 2002-04-02

Family

ID=27214080

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001289916A Abandoned AU2001289916A1 (en) 2000-09-22 2001-09-24 Methods for improving the antagonistic/agonistic properties of peptidic antagonists/agonists of the corticotropin-releasing factor receptor (crfr)

Country Status (5)

Country Link
US (1) US20040049009A1 (de)
EP (1) EP1319024A2 (de)
AU (1) AU2001289916A1 (de)
CA (1) CA2427490A1 (de)
WO (1) WO2002024732A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080221021A1 (en) * 2004-01-19 2008-09-11 Max-Planck-Gesellschaft Zur Forderung Der Novel Corticotropin-Releasing Factor Receptor 1 (Crfr1) Agonist
US7815905B2 (en) 2006-01-27 2010-10-19 Research Development Foundation Methods of increasing insulin sensitivity or decreasing insulin secretion by administering corticotropin releasing factor receptor-2 inhibitors
WO2008153815A2 (en) 2007-05-30 2008-12-18 Danisco Us, Inc., Genencor Division Variants of an alpha-amylase with improved production levels in fermentation processes
US9717522B2 (en) 2009-08-31 2017-08-01 Applied Medical Resources Corporation Multi-functional surgical access system
KR20210019487A (ko) * 2018-06-11 2021-02-22 유니버시티 오브 플로리다 리서치 파운데이션, 아이엔씨. 스트레스 관련 장애 및 암의 치료를 위한 물질 및 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824771A (en) * 1994-12-12 1998-10-20 The Salk Institute For Biological Studies Cyclic CRF agonists
US5777073A (en) * 1994-12-12 1998-07-07 The Salk Institute For Biological Studies Cyclic CRF antagonist peptides
US6323312B1 (en) * 1994-12-12 2001-11-27 The Salk Institute For Biological Studies Cyclic CRF antagonist peptides
US5663292A (en) * 1994-12-12 1997-09-02 The Salk Institute For Biological Studies Cyclic CRF analogs
US6326463B1 (en) * 1994-12-12 2001-12-04 The Salk Institute For Biological Studies Cyclic CRF agonists
US6670140B2 (en) * 2001-03-06 2003-12-30 The Procter & Gamble Company Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
EP1402271A2 (de) * 2001-05-25 2004-03-31 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Benzophenon gebundene crf und crf-ähnliche-peptide für covalente markierung von corticotropin-releasing factor (crf) bindendem protein
US7192924B2 (en) * 2002-01-16 2007-03-20 The Procter & Gamble Company Corticotropin releasing factor 2 receptor agonists

Also Published As

Publication number Publication date
WO2002024732A3 (en) 2003-01-23
CA2427490A1 (en) 2002-03-28
EP1319024A2 (de) 2003-06-18
WO2002024732A2 (en) 2002-03-28
US20040049009A1 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
AU5716901A (en) G protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same
IL160837A0 (en) Toll-like receptor 3 signaling agonists and antagonists
IL198800A0 (en) Growth differentiation factor receptors, agonists and antagonists thereof and methods of using same
AU2002366384A1 (en) Insulin and igf-1 receptor agonists and antagonists
HUP0401437A3 (en) Adenosine a3 receptor agonists
WO2003029262A3 (en) The human mob-5 (il-24) receptors and uses thereof
AUPR833401A0 (en) G protein-coupled receptor antagonists
SG149693A1 (en) Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
HK1091403A1 (en) 5-ht 1a receptor subtype agonist
AU2002367424A1 (en) Androgen receptor antagonists
EP1192945A3 (de) Verwendung von einem Östrogen Agonist/Antagonist zur Behandlung von Osteoarthritis
AU2002213409A1 (en) Galphaqproetin variants and their use in the analysis and discovery of agonists and antagonists of chemosensory receptors
IL158701A0 (en) Novel use of nk3 receptor antagonist
EP1453503A4 (de) Ep4-rezeptor-agonist, zusammensetzungen und methoden
AU2002351730A1 (en) Glucagon receptor antagonists/inverse agonists
AU2002365655A1 (en) 5-ht7 receptor antagonists
AU2001246934A1 (en) Agonist antibodies
AU2002212888A1 (en) Composition comprising: serotonin receptor antagonists (5ht-2, 5ht-3) and agonist (5ht-4)
AU2001289916A1 (en) Methods for improving the antagonistic/agonistic properties of peptidic antagonists/agonists of the corticotropin-releasing factor receptor (crfr)
EP1296958A4 (de) Iminopyrimidin nmda nr2b receptorantagonisten
EP1224155A4 (de) Neue bizyklische cannabinoid-agonisten für den cannabinoid-rezeptor
AU2002226048A1 (en) Urotensin-ii receptor antagonists
AU2002239506A1 (en) Urotensin-ii receptor antagonists
AU5861900A (en) Receptor agonists and antagonists
AU2001225663A1 (en) A composition comprising a combination of receptor agonists and antagonists